Anakinra dosing study for preterm infants
Treatments studied
Part of Genetic & congenital, Lungs & breathing, Women’s health & pregnancy clinical trials.
This trial tests different doses and ways of giving a medicine called anakinra to preterm babies. It aims to find the safest and most effective dose to help reduce inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born between 24 weeks and 28 weeks plus 6 days of pregnancy.
- Your baby does not have a known genetic syndrome.
- Your baby does not have severe heart problems.
- Your baby did not have a stroke before birth.
- Your baby does not have a hole in the diaphragm (congenital diaphragmatic hernia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called anakinra can help prevent dangerous drops in blood sugar that happen after eating in people who have had their entire stomach removed. The medication works by reducing inflammation in the body, which may help regulate blood sugar levels.
This is an early-stage study testing a new injectable treatment called KT502 for people with moderate-to-severe rheumatoid arthritis (RA) that hasn't responded well to standard treatments. The study will check if the medication is safe and how the body responds to it.
This trial tests whether a medicine called anakinra can help children with acute myocarditis (heart inflammation) in the ICU. It aims to see if the drug reduces heart damage and improves recovery.
This trial tests whether anakinra is at least as effective as standard treatment for children with Kawasaki disease. It aims to prevent heart complications caused by inflammation in the blood vessels.
This study tests whether a medication called anakinra can help treat asthma attacks in people who already take daily asthma controller medications. Anakinra works by reducing inflammation in the airways, and researchers want to see if it can help people recover faster from moderate asthma flare-ups.
This study tests whether a drug called anakinra can improve how your heart responds to inotrope therapy (medicines that help your heart pump). It is for people with advanced heart failure who are already on a steady dose of these medicines and have signs of inflammation. The goal is to see if blocking inflammation helps your heart work better.
Hear when a new Premature Infants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.